Exact Mass: 539.2355418
Exact Mass Matches: 539.2355418
Found 230 metabolites which its exact mass value is equals to given mass value 539.2355418
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
8beta,9alpha-dihydroxy-10-O-methyl-10-epiryanodine
Ala Thr Trp Tyr
Ala Thr Tyr Trp
Ala Trp Thr Tyr
Ala Trp Tyr Thr
Ala Tyr Thr Trp
Ala Tyr Trp Thr
Asp Phe Lys Met
Asp Phe Met Lys
Asp Lys Phe Met
Asp Lys Met Phe
Asp Met Phe Lys
Asp Met Lys Phe
Asp Arg Ser Tyr
C22H33N7O9 (539.2339648000001)
Asp Arg Tyr Ser
C22H33N7O9 (539.2339648000001)
Asp Ser Arg Tyr
C22H33N7O9 (539.2339648000001)
Asp Ser Tyr Arg
C22H33N7O9 (539.2339648000001)
Asp Tyr Arg Ser
C22H33N7O9 (539.2339648000001)
Asp Tyr Ser Arg
C22H33N7O9 (539.2339648000001)
Phe Asp Lys Met
Phe Asp Met Lys
Phe Lys Asp Met
Phe Lys Met Asp
Phe Met Asp Lys
Phe Met Lys Asp
Phe Asn Pro Tyr
Phe Asn Tyr Pro
Phe Pro Asn Tyr
Phe Pro Tyr Asn
Phe Ser Thr Trp
Phe Ser Trp Thr
Phe Thr Ser Trp
Phe Thr Trp Ser
Phe Trp Ser Thr
Phe Trp Thr Ser
Phe Tyr Asn Pro
Phe Tyr Pro Asn
His Gln Gln Gln
Ile Met Asn Tyr
Ile Met Tyr Asn
Ile Asn Met Tyr
Ile Asn Tyr Met
Ile Tyr Met Asn
Ile Tyr Asn Met
Lys Asp Phe Met
Lys Asp Met Phe
Lys Phe Asp Met
Lys Phe Met Asp
Lys Met Asp Phe
Lys Met Phe Asp
Lys Met Met Met
C21H41N5O5S3 (539.2269696000001)
Leu Met Asn Tyr
Leu Met Tyr Asn
Leu Asn Met Tyr
Leu Asn Tyr Met
Leu Tyr Met Asn
Leu Tyr Asn Met
Met Asp Phe Lys
Met Asp Lys Phe
Met Phe Asp Lys
Met Phe Lys Asp
Met Ile Asn Tyr
Met Ile Tyr Asn
Met Lys Asp Phe
Met Lys Phe Asp
Met Lys Met Met
C21H41N5O5S3 (539.2269696000001)
Met Leu Asn Tyr
Met Leu Tyr Asn
Met Met Lys Met
C21H41N5O5S3 (539.2269696000001)
Met Met Met Lys
C21H41N5O5S3 (539.2269696000001)
Met Asn Ile Tyr
Met Asn Leu Tyr
Met Asn Tyr Ile
Met Asn Tyr Leu
Met Gln Val Tyr
Met Gln Tyr Val
Met Val Gln Tyr
Met Val Tyr Gln
Met Tyr Ile Asn
Met Tyr Leu Asn
Met Tyr Asn Ile
Met Tyr Asn Leu
Met Tyr Gln Val
Met Tyr Val Gln
Asn Phe Pro Tyr
Asn Phe Tyr Pro
Asn Ile Met Tyr
Asn Ile Tyr Met
Asn Leu Met Tyr
Asn Leu Tyr Met
Asn Met Ile Tyr
Asn Met Leu Tyr
Asn Met Tyr Ile
Asn Met Tyr Leu
Asn Pro Phe Tyr
Asn Pro Tyr Phe
Asn Tyr Phe Pro
Asn Tyr Ile Met
Asn Tyr Leu Met
Asn Tyr Met Ile
Asn Tyr Met Leu
Asn Tyr Pro Phe
Pro Phe Asn Tyr
Pro Phe Tyr Asn
Pro Asn Phe Tyr
Pro Asn Tyr Phe
Pro Tyr Phe Asn
Pro Tyr Asn Phe
Gln His Gln Gln
Gln Met Val Tyr
Gln Met Tyr Val
Gln Gln His Gln
Gln Gln Gln His
Gln Val Met Tyr
Gln Val Tyr Met
Gln Tyr Met Val
Gln Tyr Val Met
Arg Asp Ser Tyr
C22H33N7O9 (539.2339648000001)
Arg Asp Tyr Ser
C22H33N7O9 (539.2339648000001)
Arg Ser Asp Tyr
C22H33N7O9 (539.2339648000001)
Arg Ser Tyr Asp
C22H33N7O9 (539.2339648000001)
Arg Tyr Asp Ser
C22H33N7O9 (539.2339648000001)
Arg Tyr Ser Asp
C22H33N7O9 (539.2339648000001)
Ser Asp Arg Tyr
C22H33N7O9 (539.2339648000001)
Ser Asp Tyr Arg
C22H33N7O9 (539.2339648000001)
Ser Phe Thr Trp
Ser Phe Trp Thr
Ser Arg Asp Tyr
C22H33N7O9 (539.2339648000001)
Ser Arg Tyr Asp
C22H33N7O9 (539.2339648000001)
Ser Thr Phe Trp
Ser Thr Trp Phe
Ser Trp Phe Thr
Ser Trp Thr Phe
Ser Tyr Asp Arg
C22H33N7O9 (539.2339648000001)
Ser Tyr Arg Asp
C22H33N7O9 (539.2339648000001)
Thr Ala Trp Tyr
Thr Ala Tyr Trp
Thr Phe Ser Trp
Thr Phe Trp Ser
Thr Ser Phe Trp
Thr Ser Trp Phe
Thr Trp Ala Tyr
Thr Trp Phe Ser
Thr Trp Ser Phe
Thr Trp Tyr Ala
Thr Tyr Ala Trp
Thr Tyr Trp Ala
Val Met Gln Tyr
Val Met Tyr Gln
Val Gln Met Tyr
Val Gln Tyr Met
Val Tyr Met Gln
Val Tyr Gln Met
Trp Ala Thr Tyr
Trp Ala Tyr Thr
Trp Phe Ser Thr
Trp Phe Thr Ser
Trp Ser Phe Thr
Trp Ser Thr Phe
Trp Thr Ala Tyr
Trp Thr Phe Ser
Trp Thr Ser Phe
Trp Thr Tyr Ala
Trp Tyr Ala Thr
Trp Tyr Thr Ala
Tyr Ala Thr Trp
Tyr Ala Trp Thr
Tyr Asp Arg Ser
C22H33N7O9 (539.2339648000001)
Tyr Asp Ser Arg
C22H33N7O9 (539.2339648000001)
Tyr Phe Asn Pro
Tyr Phe Pro Asn
Tyr Ile Met Asn
Tyr Ile Asn Met
Tyr Leu Met Asn
Tyr Leu Asn Met
Tyr Met Ile Asn
Tyr Met Leu Asn
Tyr Met Asn Ile
Tyr Met Asn Leu
Tyr Met Gln Val
Tyr Met Val Gln
Tyr Asn Phe Pro
Tyr Asn Ile Met
Tyr Asn Leu Met
Tyr Asn Met Ile
Tyr Asn Met Leu
Tyr Asn Pro Phe
Tyr Pro Phe Asn
Tyr Pro Asn Phe
Tyr Gln Met Val
Tyr Gln Val Met
Tyr Arg Asp Ser
C22H33N7O9 (539.2339648000001)
Tyr Arg Ser Asp
C22H33N7O9 (539.2339648000001)
Tyr Ser Asp Arg
C22H33N7O9 (539.2339648000001)
Tyr Ser Arg Asp
C22H33N7O9 (539.2339648000001)
Tyr Thr Ala Trp
Tyr Thr Trp Ala
Tyr Val Met Gln
Tyr Val Gln Met
Tyr Trp Ala Thr
Tyr Trp Thr Ala
Amcasertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Lys-Met-Met-Met
C21H41N5O5S3 (539.2269696000001)
A tetrapeptide composed of L-lysine and three L-methionine units joined in sequence by peptide linkages.
(3S,6aS,8S,10aS)-3-hydroxy-8-[2-[2-(1-methylimidazol-4-yl)ethylamino]-2-oxoethyl]-N-[4-(trifluoromethyl)phenyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(3R,6aR,8R,10aR)-3-hydroxy-8-[2-[2-(1-methyl-4-imidazolyl)ethylamino]-2-oxoethyl]-N-[4-(trifluoromethyl)phenyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(3S,6aR,8R,10aR)-3-hydroxy-8-[2-[2-(1-methyl-4-imidazolyl)ethylamino]-2-oxoethyl]-N-[4-(trifluoromethyl)phenyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(3S,6aR,8S,10aR)-3-hydroxy-8-[2-[2-(1-methyl-4-imidazolyl)ethylamino]-2-oxoethyl]-N-[4-(trifluoromethyl)phenyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(3R,6aR,8S,10aR)-3-hydroxy-8-[2-[2-(1-methyl-4-imidazolyl)ethylamino]-2-oxoethyl]-N-[4-(trifluoromethyl)phenyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(3R,6aS,8S,10aS)-3-hydroxy-8-[2-[2-(1-methyl-4-imidazolyl)ethylamino]-2-oxoethyl]-N-[4-(trifluoromethyl)phenyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(3S,6aS,8R,10aS)-3-hydroxy-8-[2-[2-(1-methyl-4-imidazolyl)ethylamino]-2-oxoethyl]-N-[4-(trifluoromethyl)phenyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
Akt1/Akt2-IN-1
Akt1/Akt2-IN-1 (Compound 17) is an allosteric inhibitor of Akt1 (IC50=3.5 nM) and Akt2 (IC50=42 nM), with potent and balanced activity[1].
MDM2-p53-IN-16
MDM2-p53-IN-16 is a MDM2-p53 complex inhibitor with an IC50 value of 4.3 nM to dissociate human p53/MDM2 complex. MDM2-p53-IN-16 reactivates p53, and induces Glioblastoma Multiforme (GBM) cell apoptosis and cell-cycle arrest. MDM2-p53-IN-16 can be used for the cancer research[1].
n-{5,8-dihydroxy-7-[hydroxy(phenyl)methyl]-3-isopropyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),5,8,10,12,15-hexaen-4-yl}-3-phenylprop-2-enimidic acid
n-(6-amino-1-oxohex-4-en-2-yl)-3-[(4-{4-[(2-carbamimidamido-1-hydroxyethylidene)amino]-1h-pyrrole-2-amido}-1h-pyrrol-2-yl)formamido]-3-cyanopropanimidic acid
(3r,3ar,4s,6ar,9ar,9br)-9-methyl-6-methylidene-2-oxo-4-[(3s)-piperidin-3-yloxy]-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-3-carboxylic acid
(2s)-2-{[(2s)-2-{[(2s)-2-{[(2s)-2,6-diamino-1-hydroxyhexylidene]amino}-1-hydroxy-4-(methylsulfanyl)butylidene]amino}-1-hydroxy-4-(methylsulfanyl)butylidene]amino}-4-(methylsulfanyl)butanoic acid
C21H41N5O5S3 (539.2269696000001)